China’s first key national R&D project equipment for high-altitude wind energy.Screenshot of CMG's report/ People's Daily China has successfully completed flight tests of the world’s largest ...
Local birder Clarence Yeung, who lives fewer than 10 minutes from the park, rushed out with his camera after the alert on eBird's rare bird alert system. For Yeung, it was a "lifer"—a term birders use ...
Kite, an artificial intelligence (AI)-powered payments blockchain, rolled out its native token on Monday, generating significant trading volume on South Korean exchanges Upbit and Bithumb. The token ...
Even as many big pharma companies are retreating from cell therapies, Gilead subsidiary Kite Pharma has entered a global licensing agreement with Chinese biotech Pregene. Under the terms of the deal, ...
The killer app of the world wide web was the browser. The browser is a front-facing app. Until the browser came along there was no way for users to easily access texts written in html. With the ...
Minesto, a marine energy technology developer based in Sweden, is a winner of the 2025 Gizmodo Science Fair for deploying the first operational, megawatt-scale tidal energy kite in the Faroe Islands.
Community driven content discussing all aspects of software development from DevOps to design patterns. Ready to develop your first AWS Lambda function in Python? It really couldn’t be easier. The AWS ...
Capital includes assets like cash, machinery, and patents used to create value. Businesses acquire capital through equity, debt, or retaining earnings. Capital investment decisions are based on the ...
Gilead Sciences' Kite Pharma has cut off a collaboration with Shoreline Biosciences, ending a research collaboration on off-the-shelf cell therapies that was valued at more than $2.3 billion. The deal ...
The round, co-led by General Catalyst and PayPal Ventures, brings the San Francisco-based startup’s cumulative funding to $33 million, according to an emailed announcement on Tuesday. Formerly known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback